The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein

Journal of the Autonomic Nervous System

Volumn 61, Issue 2, 1996, Pages 149-154

  Nishizawa, Makoto ^a   Nakabayashi, Hajime ^b   Uchida, Kenzo ^a   Nakagawa, Atsushi ^b   Niijima, Akira ^c  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Insulinotropic gut factor; Portal vein; Rat; Vagal hormone reception

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HORMONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INSULIN LIKE ACTIVITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; VAGUS NERVE;

AFFERENT PATHWAYS; ANIMALS; ELECTROPHYSIOLOGY; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; INJECTIONS, INTRAVENOUS; LIVER; MALE; NEUROTRANSMITTER AGENTS; PEPTIDE FRAGMENTS; PORTAL VEIN; RATS; RATS, WISTAR; VAGUS NERVE;

EID: 0030572882     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(96)00071-9     Document Type: Article

References (35)

1. [1] Berthoud, H.R., Kressel, M. and Neuhuber, W.L., An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system, Anat. Embryol., 186 (1992) 431-442.
2. [2] Blackmore, P.F., Mojsov, S., Exton, J.H. and Habener, J.F., Absence of insulinotropic glucagon-like peptide-I (7-37) receptors on isolated rat liver hepatocytes. FEBS Lett., 283 (1991) 7-10.
3. [3] Brubaker, P.L., Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides, Endocrinology, 128 (1991) 3175-3182.
4. [4] Buchan, A.M., Polak, J.M., Capella, C., Solcia, E. and Pearse, A.G.E., Electron immunocytochemical evidence tor the K cell localization of gastric inhibitory polypeptide (GIP) in man, Histochemistry, 56 (1978) 37-44.
5. [5] Campos, R.V., Lee, Y.C. and Drucker, D.J., Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse, Endocrinology, 134 (1994) 2156-2164.
6. [6] Dupre, J., Influences of the gut on the endocrine pancreas: an overview of established and potential physiological mechanisms. In E. Samols (Ed.), The endocrine pancreas, Raven Press. New York, 1991, pp. 253-281.
7. [7] Eissele, R., Göke, R., Willemer, S., Harthus, H.P., Vermeer, H., Arnold, R. and Göke, B., Glucagon-like peptide 1 cells in the gastrointestinal tract and pancreas of rat, pig and man, Eur. J. Clin. Invest., 22 (1992) 283-291.
8. [8] Elliott, R.M., Morgan, L.M., Tredger, J.A., Deacon, S., Wright, J. and Marks, V., Glucagon-like peptide-1(7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns, J. Endocrinol., 138 (1993) 159-166.
9. [9] Han, V.K.M., Hynes, M.A., Jin, C., Towle, A.C., Lauder, J.M. and Lund, P.K., Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain. J. Neurosci. Res., 16 (1986) 97-107.
10. [10] Jin, S.L.C., Han, V.K.M., Simmons, J.G., Towle, A.C., Lauder, J.M. and Lund, P.K., Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study, J. Comp. Neurol., 271 (1988) 519-532.
11. [11] Jorde, R., Burhol, P.G. and Schulz T.B., Fasting and postprandial plasma GIP values in man measured with seven different antisera, Regul. Pept., 7 (1983) 87-94.
12. [12] Kanse, S.M., Kreymann, B., Ghatei, M.A. and Bloom, S.R., Identification and characterization of glucagon-like peptide-1 7-36 amide-binding sites in the rat brain and lung. FEBS Lett., 241 (1988) 209-212.
13. [13] Kreymann, B., Williams, G., Ghatei, M.A. and Bloom, S.R., Glucagon-like peptide-1 7-36: a physiological incretin in man, Lancet, 2 (1987) 1300-1304.
14. [14] Nakabayashi, H., Kobayashi, K., Nakabayashi, I.O. and Kurata, Y., Somatostatin receptor on the afferent nerve terminals in the rat hepatoportal area. Neurosci. Lett., 183 (1995) 46-49.
15. [15] Nakabayashi, H., Niijima, A., Kurata, Y., Jiang, Z.Y., Usukura, N. and Takeda, R., Pancreatic vagal nerve is receptive to somatostatin in rats, Am. J. Physiol., 253 (1987) R200-R203.
16. [16] Nakabayashi, H., Niijima, A., Kurata, Y., Usukura, N. and Takeda, R., Somatostatin-sensitive neural system in the liver, Neurosci. Lett., 67 (1986) 78-81.
17. [17] Nakabayashi, H., Niijima, A., Nishizawa, M., Nakabayashi, I.O. and Takeda, R., A unique receptor-mediated mechanism in vagal chemoreception of somatostatin in the hepatoportal area, J. Auton. Nerv. Syst., 50 (1994) 45-50.
18. [18] Nakabayashi, I.O. and Nakabayashi, H., Monoclonal antibodies to somatostatin receptor of rat brain, Hybridoma, 11 (1992) 789-794.
19. [19] Niijima A., Afferent discharges from osmoreceptors in the liver of the guinea pig. Science, 166 (1969) 1519-1520.
20. [20] Niijima, A., Glucose-sensitive afferent nerve fibres in the hepatic branch of the vagus nerve in the guinea-pig, J. Physiol. London, 332 (1982) 315-323.
21. [21] Orskov, C., Jeppesen, J., Madsbad, S. and Holst, J.J., Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine, J. Clin. Invest., 87 (1991) 415-423.
22. [22] Orskov, C., Rabenhoj, L., Wettergren, A., Kofod, H. and Holst, J.J., Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes, 43 (1994) 535-539.
23. [23] Plaisancie, P., Bernard, C., Chayvialle, J.A. and Cuber, J.C., Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon, Endocrinology, 135 (1994) 2398-2403.
24. [24] Roberge, J.N. and Brubaker, P.L., Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop, Endocrinology, 133 (1993) 233-240.
25. [25] Russek, M., Participation of hepatic glucoreceptors in the control of intake of food, Nature London, 197 (1963) 79-80.
26. [26] Sawchenko, P.E. and Friedman, M.I., Sensory functions of the liver - a review, Am. J. Physiol., 236 (1979) R5-20.
27. [27] Schulz, T.B., Jorde, R. and Burhol, P.G., Gastric inhibitory polypeptide release into the portal vein in response to intraduodenal amino acid loads in anesthetized rats. Scand. J. Gastroenterol., 17 (1982) 709-713.
28. [28] Shimizu, I., Hirota, M., Ohboshi, C. and Shima, K., Identification and localization of glucagon-like peptide-1 and its receptor in rat brain, Endocrinology, 121 (1987) 1076-1082.
29. [29] Suzuki, S., Kawai, K., Ohashi, H., Mukai, H. and Yamashita, K., Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas., Endocrinology, 125 (1989) 3109-3114.
30. [30] Suzuki, S., Kawai, K., Ohashi, S., Watanabe, Y. and Yamashita, K., Comparison of the insulinotropic activity of glucagon-superfamily peptides in rat pancreas perfusion, Horm. Metab. Res., 24 (1992) 458-461.
31. [31] Tseng, C-C., Jarboe, L.A., Landau, S.B., Williams, E.K. and Wolfe, M.M., Glucose-dependent insulinotropic peptide: Structure of the precursor and tissue-specific expression in rat, Biochemistry, 90 (1993) 1992-1996.
32. [32] Usdin, T.B., Mezey, E., Button, D.C., Brownstein, M.J. and Bonner, T.I., Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain, Endocrinology, 133 (1993) 2861-2870.
33. [33] Uttenthal, L.O., Toledano, A. and Blazquez, E., Autoradiographic localization of receptors for glucagon-like peptide-1 (7-36) amide in rat brain, Neuropeptides, 21 (1992) 143-146.
34. [34] Varndell, I.M., Bishop, A.E., Sikri, K.L., Uttenthal, L.O., Bloom, S.R. and Polak, J.M., Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry, J. Histochem. Cytochem., 33 (1985) 1080-1086.
35. [35] Wang, Z., Wang, R.M., Owji, A.A., Smith, D.M., Ghatei, M.A. and Bloom, S.R., Glucagon-like peptide-1 is a physiological incretin in rat, J. Clin. Invest., 95 (1995) 417-421.